Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
暂无分享，去创建一个
E. Crestani | A. Burks | B. Vickery | Julie Wang | J. Bird | S. Laubach | A. Cianferoni | Edwin H. Kim | J. Spergel | B. Davis | R. Rachid | J. Heimall | S. Leonard | A. MacGinnitie | A. Assa'ad | S. Jones | A. Burks | Stephanie A. Leonard | J. A. Bird | Stacie M. Jones | Amal Assa'ad | Susan S. Laubach | Benjamin P. Davis